InvestorsHub Logo
Followers 494
Posts 32141
Boards Moderated 0
Alias Born 03/12/2014

Re: bidmark post# 8825

Tuesday, 11/14/2023 6:00:20 PM

Tuesday, November 14, 2023 6:00:20 PM

Post# of 8928
HC Wainwright & Co. analyst Joseph Pantginis maintains Capricor Therapeutics (NASDAQ:CAPR) with a Buy and raises the price target from $18 to $40.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CAPR News